Arterial Line in Trauma Resuscitation (ALTR)

November 10, 2024 updated by: National Taiwan University Hospital

Enhancing Trauma Resuscitation Through Arterial Line Integration: A Before-After Study

Accident-related deaths is the 7th leading cause of death in Taiwan, and most of them is due to trauma from falls and traffic accident. Among trauma patients, the common cause of death is from hemorrhagic shock. Thus, real-time and accurate blood pressure monitoring is important for trauma patients. Incorrect blood pressure monitoring can lead to adverse events like traumatic cardiac arrest and shock and can also delay the time for intervention (fluid resuscitation, blood transfusion and operation). The current practice of blood pressure monitoring in trauma patient is by non-invasive blood pressure monitoring, which may be incorrect and not timely. Patient's body type and peripheral perfusion can both influence the result of non-invasive blood pressure monitoring.

With continuous and correct blood pressure monitoring, the resuscitation team can give adequate and timely treatment. In some trauma centers, arterial line insertion in trauma patients is a daily practice, while the evidence is inadequate and the potential benefit in unknown.

The main purpose of this study is to investigate the application of arterial line insertion in trauma patients. The study design is a prospective before-after study to exam whether arterial line insertion in trauma patients can reduce adverse event rate like hypovolemic shock and improve patient's outcomes.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

216

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Douliu, Taiwan
        • National Taiwan University Hospital Yunlin Branch

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Glasgow Coma Scale (GCS) 13 or less
  • SBP < 90 mmHg
  • Respiratory rate < 10 or > 29 breaths/min
  • Fall from height > 6 meters
  • High-Risk Auto Crash: Partial or complete ejection, intrusion > 30 cm any site, Need for extrication for entrapped patient, Death in passenger compartment
  • Rider separated from transport vehicle with significant impact
  • Penetrating injuries to head, neck, torso, and proximal extremities
  • Skull deformity, suspected skull fracture
  • Chest wall instability, deformity, or suspected flail chest
  • Suspected pelvic fracture
  • Suspected fracture of two or more proximal long bones
  • Amputation proximal to wrist or ankle
  • Active bleeding requiring a tourniquet or wound packing with continuous pressure
  • Burns in conjunction with trauma

Exclusion Criteria:

  • Pregnancy
  • Patient or family who are unable to obtain informed consent
  • Known coagulopathy that is inappropriate for arterial line insertion
  • Known peripheral arterial occlusion disease that is inappropriate for arterial line insertion
  • traumatic cardiac arrest

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: trauma patients with arterial line insertion
the after phase, actively recruited patients who are eligible for arterial line insertion
insert arterial line for patients who meet major trauma criteria
No Intervention: trauma patients without arterial line insertion
the before phase, retrospectively data collection from the past

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
composite primary endpoint (including any hypotension, vasopressors usage, any cardiac arrest in ER, Shock index )
Time Frame: during ER stay, up to 6 hours
including any hypotension, vasopressors usage, any cardiac arrest in ER, Shock index (HR/SBP)>1
during ER stay, up to 6 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
prolong ICU admission
Time Frame: up to 7 days
define as > 6 days of admission
up to 7 days
30 days mortality rate
Time Frame: mortality within 30 days of trauma event
mortality within 30 days of trauma event
mortality within 30 days of trauma event
volume of fluid administration
Time Frame: during ER stay, up to 6 hours
any type of fluid administration
during ER stay, up to 6 hours
units of red blood cell transfusion
Time Frame: during ER stay, up to 6 hours
units of red blood cell transfusion
during ER stay, up to 6 hours
Area under curve (AUC) difference under different time measuring frequency
Time Frame: 1/3/5/10 minutes
We will use continuous blood pressure data and apply different intervals (1, 3, 5, and 10 minutes) to create a plot, then smooth it to calculate the area under the curve (AUC).
1/3/5/10 minutes
arterial blood pressure trajectory
Time Frame: during ER stay, up to 6 hours
We will depict the arterial blood pressure trajectory for each patient.
during ER stay, up to 6 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2023

Primary Completion (Estimated)

December 31, 2024

Study Completion (Estimated)

June 30, 2025

Study Registration Dates

First Submitted

August 3, 2023

First Submitted That Met QC Criteria

August 10, 2023

First Posted (Actual)

August 16, 2023

Study Record Updates

Last Update Posted (Estimated)

November 13, 2024

Last Update Submitted That Met QC Criteria

November 10, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 202210095DINC

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Major Trauma

Clinical Trials on arterial line

Subscribe